Close

Tag: Coronavirus information (COVID-19)

The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate

CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland announced that they have entered into a new, significant partnering agreement...

Messe Frankfurt to focus on highlighting strong anti-counterfeiting measures in wake of Covid-19

As demand for medical supplies soars worldwide in the fight against Covid-19, there is a parallel risk of substandard and counterfeit medicines in the...

Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19

Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), announced results...

LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials

LabCorp , a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has...

Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans

Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19. This investigational...

Biocair Transports Plasmids For COVID-19 Research in South Africa

Biocair, a global specialist in life sciences logistics, was selected to transport time-critical plasmids from the USA to the Africa Health Research Institute (AHRI)...

Moderna Extends Lipid Supply for Coronavirus Vaccine

CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read